NEP

1. 2026-10-19issueIssued info_card
2. 2026-09-24srcAnalytical Challenges in Detecting NPS in Anti-Doping: A Proof-of-Concept Involving Pentedrone Metabolite
3. 2026-09-24srcStructure-Activity Relationships of Synthetic Cathinones.
4. 2026-09-24srcDesigner drugs: mechanism of action and adverse effects
5. 2026-09-24srcSynthesis of emerging cathinones and validation of a SPE GC-MS method for their simultaneous quantification in blood.
6. 2026-09-24srcSynthetic cathinones in drug-facilitated sexual assault: A case report involving N-ethylpentedrone
7. 2026-09-24srcNew psychoactive substances - 96 cases of deaths related to their use based on forensic toxicological practice.
8. 2026-09-24srcMetabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS.
9. 2026-09-24srcComparison of authentic urine N-ethylpentedrone metabolites to predicted in silico and in vitro human hepatocyte metabolism.
10. 2026-09-24srcFirst enantioselective determination of N-ethylpentedrone and its major phase-1 metabolites using supercritical fluid chromatography coupled with tandem mass spectrometry and its application to human oral fluid and urine samples.
11. 2026-09-24srcMonoamine transporter and receptor interaction profiles of a new series of designer cathinones
12. 2026-09-24srcRole of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones.
13. 2026-09-24srcStructure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones.
14. 2026-09-24srcLocomotor stimulant and drug discrimination effects of five synthetic cathinones in rodents
15. 2026-09-24srcRepeated administration of N-ethyl-pentedrone induces increased aggression and impairs social exploration after withdrawal in mice
16. 2026-09-24srcThe combination of ethanol with mephedrone increases the signs of neurotoxicity and impairs neurogenesis and learning in adolescent CD-1 mice.
17. 2026-09-24srcToxicological Analysis of Cases of Mixed Poisonings with Synthetic Cathinones and Other Drugs of Abuse.
18. 2026-09-24srcSynthetic Cathinones in Belgium: Two Case Reports with Different Outcomes Observed in the Emergency Room
19. 2026-09-24srcThe new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity.
20. 2026-09-24srcPharmacological characterization of designer cathinones in vitro
21. 2026-09-24srcUnderreporting of synthetic cathinone poisoning with clinical immunoassays: An experimental and observational study.
22. 2026-09-24srcEmerging drugs of abuse: current perspectives on substituted cathinones
23. 2026-09-24srcThe Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
24. 2026-09-24srcSchedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4′-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4′-Chloro-alpha-pyrrolidinovalerophenone in Schedule I
25. 2026-09-24srcEUDA initial report on the new psychoactive substance N-ethylnorpentedrone (NEP)
26. 2026-09-24srcN-Ethylpentedrone PubChem Entry (CID 205593)
27. 2026-09-04issueIssued emergency
28. 2026-09-04issueIssued info_card
29. 2026-09-04issueIssued notice
30. 2026-06-04proposal42 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
31. 2026-06-04publicationPublication — backfill
32. 2026-04-26revisionRevision 1
33. 2026-04-26absenceSearched ClinicalTrials.gov for "N-ethylpentedrone synthetic cathinone" — no results
34. 2026-04-26genGeneration — pipeline-v5 · with 2 morepipeline-v5
35. 2026-04-26rungeneration run

The same entries, as forms: six forms.